B M Everett

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial
    Brendan M Everett
    The Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Ther 30:661-72. 2008
  2. pmc Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study)
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    Am J Cardiol 116:532-7. 2015
  3. pmc High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy
    Brendan M Everett
    From Divisions of Cardiovascular B M E, P M R and Preventive Medicine B M E, R J G, P M R, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA University Heart Centre Hamburg, Clinic for General and Interventional Cardiology, Germany T Z, S B and German Centre for Cardiovascular Research Partner Site Hamburg Lübeck Kiel, Germany T Z, S B
    Circulation 131:1851-60. 2015
  4. pmc B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women
    Brendan M Everett
    Division of Cardiovascular Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    J Am Coll Cardiol 64:1789-97. 2014
  5. doi request reprint Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER)
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    Am J Cardiol 114:1682-9. 2014
  6. pmc Novel genetic markers improve measures of atrial fibrillation risk prediction
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Eur Heart J 34:2243-51. 2013
  7. pmc Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis
    Brendan M Everett
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am Heart J 166:199-207.e15. 2013
  8. pmc Aging syndrome genes and premature coronary artery disease
    Adrian F Low
    Cardiovascular Research Center and Cardiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA
    BMC Med Genet 6:38. 2005
  9. pmc Interleukin-18 and the risk of future cardiovascular disease among initially healthy women
    Brendan M Everett
    The Leducq Center for Molecular and Genetic Epidemiology, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, United States
    Atherosclerosis 202:282-8. 2009
  10. pmc The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women
    Brendan M Everett
    Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
    J Am Coll Cardiol 48:2235-42. 2006

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial
    Brendan M Everett
    The Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Ther 30:661-72. 2008
    ....
  2. pmc Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study)
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    Am J Cardiol 116:532-7. 2015
    ....
  3. pmc High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy
    Brendan M Everett
    From Divisions of Cardiovascular B M E, P M R and Preventive Medicine B M E, R J G, P M R, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA University Heart Centre Hamburg, Clinic for General and Interventional Cardiology, Germany T Z, S B and German Centre for Cardiovascular Research Partner Site Hamburg Lübeck Kiel, Germany T Z, S B
    Circulation 131:1851-60. 2015
    ..Cardiac troponin and B-type natriuretic peptide (BNP) concentrations are associated with adverse cardiovascular outcome in primary prevention populations. Whether statin therapy modifies this association is poorly understood...
  4. pmc B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women
    Brendan M Everett
    Division of Cardiovascular Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    J Am Coll Cardiol 64:1789-97. 2014
    ..Although N-terminal pro-B-type natriuretic peptide (NT-proBNP) has a strong relationship with incident cardiovascular disease (CVD), few studies have examined whether NT-proBNP adds to risk prediction algorithms, particularly in women...
  5. doi request reprint Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER)
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts Electronic address
    Am J Cardiol 114:1682-9. 2014
    ..These data may guide the monitoring of patients on intensive statin therapy and adverse events in trials of therapies that lead to very low LDL-C levels...
  6. pmc Novel genetic markers improve measures of atrial fibrillation risk prediction
    Brendan M Everett
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Eur Heart J 34:2243-51. 2013
    ..Atrial fibrillation (AF) is associated with adverse outcome. Whether recently discovered genetic risk markers improve AF risk prediction is unknown...
  7. pmc Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis
    Brendan M Everett
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am Heart J 166:199-207.e15. 2013
    ..Inflammation plays a fundamental role in atherothrombosis. Yet, whether direct inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is not known...
  8. pmc Aging syndrome genes and premature coronary artery disease
    Adrian F Low
    Cardiovascular Research Center and Cardiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA
    BMC Med Genet 6:38. 2005
    ..We evaluated whether common variants at the LMNA or KLOTHO genes are associated with rigorously defined premature CAD...
  9. pmc Interleukin-18 and the risk of future cardiovascular disease among initially healthy women
    Brendan M Everett
    The Leducq Center for Molecular and Genetic Epidemiology, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, United States
    Atherosclerosis 202:282-8. 2009
    ..Elevated levels of interleukin (IL)-18 have been implicated in the development of atherosclerosis in animals. Data in humans are less clear, and data in women are particularly scarce...
  10. pmc The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women
    Brendan M Everett
    Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
    J Am Coll Cardiol 48:2235-42. 2006
    ..We sought to determine the relative strength of high-sensitivity C-reactive protein (hs-CRP) and lipid levels as markers for future ischemic stroke compared with coronary heart disease (CHD) in women...
  11. doi request reprint Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)
    Brendan M Everett
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, 900 Commonwealth Ave, Boston, MA 02215, USA
    Circulation 121:143-50. 2010
    ..We evaluated whether statin therapy might reduce stroke rates among individuals with low levels of cholesterol but elevated levels of high-sensitivity C-reactive protein...
  12. pmc Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study
    Brendan M Everett
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
    Circulation 123:2811-8. 2011
    ..Whether high-sensitivity cardiac troponin T levels are associated with adverse cardiovascular outcomes in individuals without cardiovascular disease (CVD) has not been well studied...
  13. pmc Physical activity and the risk of incident atrial fibrillation in women
    Brendan M Everett
    Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
    Circ Cardiovasc Qual Outcomes 4:321-7. 2011
    ..We hypothesized that regular PA, possibly acting through reductions in blood pressure and body mass index (BMI), would reduce the risk of incident atrial fibrillation (AF) in women...
  14. pmc Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women
    B M Everett
    The Center for Cardiovascular Disease Prevention, Harvard Medical School, and the Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02215, USA
    J Thromb Haemost 7:588-96. 2009
    ..Published reports of a relationship between lipids and incident venous thromboembolism (VTE) are conflicting...
  15. pmc Lipid levels and the risk of ischemic stroke in women
    T Kurth
    Brigham and Women s Hospital, Division of Preventive Medicine, Harvard Medical School, Boston, MA 02215, USA
    Neurology 68:556-62. 2007
    ....
  16. ncbi request reprint Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial
    D Conen
    Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
    Heart 94:e13. 2008
    ....
  17. ncbi request reprint Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?"
    Paul M Ridker
    Circulation 115:e475; author reply e476. 2007
  18. ncbi request reprint Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization
    Shi Yin Foo
    Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Am Heart J 152:290.e1-7. 2006
    ..The objective was to examine prospectively the prevalence of anti-platelet factor 4 (PF4)/heparin antibodies and heparin-induced thrombocytopenia in the population undergoing cardiac catheterization...